Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-16DOI: 10.1007/s12028-024-02052-9
Stefan Yu Bögli, Crescenzo Capone, Markus R Baumgartner, Boris B Quednow, Thomas Kraemer, Emanuela Keller, Tina Maria Binz
{"title":"Delirium in Neurocritical Care: Uncovering Undisclosed Psychotropic Substance and Medication Use and Stress Exposure by Hair Analysis.","authors":"Stefan Yu Bögli, Crescenzo Capone, Markus R Baumgartner, Boris B Quednow, Thomas Kraemer, Emanuela Keller, Tina Maria Binz","doi":"10.1007/s12028-024-02052-9","DOIUrl":"10.1007/s12028-024-02052-9","url":null,"abstract":"<p><strong>Objective: </strong>In intensive care, delirium is frequent, prolongs the stay, increases health care costs, and worsens patient outcome. Several substances and medications as well as stress can impact the risk of delirium; however, assessment of previous exposure to psychotropic agents and stress by self-reports or third-party information is not always reliable. Hair analysis can be used to objectively assess medication and substance use (including chronic alcohol consumption), and allows for the determination of stress-related long-term changes in steroid hormones and endocannabinoids.</p><p><strong>Methods: </strong>Consecutive adult patients with acute brain injury admitted to the neurocritical care unit were included. Delirium was diagnosed using the Confusion Assessment Method for the Intensive Care Unit. Liquid chromatography coupled with tandem mass spectrometry was used to investigate psychoactive substances and medications, ethyl glucuronide, steroid hormones, and endocannabinoids in hair samples. Univariable and multivariable analyses were used to reveal any associations with the occurrence of delirium.</p><p><strong>Results: </strong>Of 50 consecutive patients, 21 (42%) were diagnosed with delirium. Detection of antipsychotics or antidepressants in hair was more frequent in patients with delirium (antidepressants: 43% vs. 14%, p = 0.040; antipsychotics: 29% vs. 0%, p = 0.021). These patients also displayed higher ethyl glucuronide levels (p = 0.049). Anandamide (AEA) concentrations were higher in patients with delirium (p = 0.005), whereas oleoylethanolamide (p = 0.045) and palmitoylethanolamide (PEA) (p = 0.017) concentrations were lower in patients with delirium. Backward stepwise logistic regression analysis revealed antidepressants and AEA/PEA to be independent relevant predictors of delirium.</p><p><strong>Conclusions: </strong>Hair analysis provides crucial and otherwise unattainable information regarding chronic stress and the use of psychotropic substances and medications. Undisclosed antidepressant/antipsychotic use or intense chronic alcohol consumption is susceptible to treatment (continuation of medication or provision of low-dose benzodiazepines in case of alcohol). Chronic stress can be evaluated using stress markers and endocannabinoids in hair, potentially allowing for personalized delirium risk stratification and preventive measures.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"164-174"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11811262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-31DOI: 10.1007/s12028-024-02070-7
Vedang Vyas, Sean I Savitz, Seth B Boren, Andrea Becerril-Gaitan, Khader Hasan, Robert Suchting, Constanza deDios, Spencer Solberg, Ching-Jen Chen, Robert J Brown, Clark W Sitton, James Grotta, Jaroslaw Aronowski, Nicole Gonzales, Muhammad E Haque
{"title":"Serial Diffusion Tensor Imaging and Rate of Ventricular Blood Clearance in Patients with Intraventricular Hemorrhage.","authors":"Vedang Vyas, Sean I Savitz, Seth B Boren, Andrea Becerril-Gaitan, Khader Hasan, Robert Suchting, Constanza deDios, Spencer Solberg, Ching-Jen Chen, Robert J Brown, Clark W Sitton, James Grotta, Jaroslaw Aronowski, Nicole Gonzales, Muhammad E Haque","doi":"10.1007/s12028-024-02070-7","DOIUrl":"10.1007/s12028-024-02070-7","url":null,"abstract":"<p><strong>Background: </strong>We developed a noninvasive biomarker to quantify the rate of ventricular blood clearance in patients with intracerebral hemorrhage and extension to the ventricles-intraventricular hemorrhage.</p><p><strong>Methods: </strong>We performed magnetic resonance imaging in 26 patients at 1, 14, 28, and 42 days of onset and measured their hematoma volume (HV), ventricular blood volume (VBV), and two diffusion metrics: fractional anisotropy (FA), and mean diffusivity (MD). The ipasilesional ventricular cerebral spinal fluid's FA and MD were associated with VBV and stroke severity scores (National Institute of Health Stroke Scale [NIHSS]). A subcohort of 14 patients were treated with external ventricular drain (EVD). A generalized linear mixed model was applied for statistical analysis.</p><p><strong>Results: </strong>At day 1, the average HVs and NIHSS scores were 14.6 ± 16.7 cm<sup>3</sup> and 16 ± 8, respectively. A daily rate of 2.1% and 1.3% blood clearance/resolution were recorded in HV and VBV, respectively. Ipsilesional ventricular FA (vFA) and ventricular MD (vMD) were simultaneously decreased (vFA = 1.3% per day, posterior probability [PP] > 99%) and increased (vMD = 1.5% per day, PP > 99%), respectively. Patients with EVD exhibited a faster decline in vFA (1.5% vs. 1.1% per day) and an increase in vMD (1.8% vs. 1.5% per day) as compared with patients without EVD. Temporal change in vMD was associated with VBV; a 1.00-cm<sup>3</sup> increase in VBV resulted in a 5.2% decrease in vMD (PP < 99%). VBV was strongly associated with NIHSS score (PP = 97-99%). A larger cerebral spinal fluid drained volume was associated with a greater decrease (PP = 83.4%) in vFA, whereas a smaller volume exhibited a greater increase (PP = 94.8%) in vMD.</p><p><strong>Conclusions: </strong>In conclusion, vFA and vMD may serve as biomarkers for VBV status.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"48-58"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141860427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth E Carroll, Caroline Der-Nigoghossian, Ayham Alkhachroum, Brian Appavu, Emily Gilmore, Julie Kromm, Benjamin Rohaut, Mario Rosanova, Jacobo Diego Sitt, Jan Claassen
{"title":"Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Electrophysiology Working Group.","authors":"Elizabeth E Carroll, Caroline Der-Nigoghossian, Ayham Alkhachroum, Brian Appavu, Emily Gilmore, Julie Kromm, Benjamin Rohaut, Mario Rosanova, Jacobo Diego Sitt, Jan Claassen","doi":"10.1007/s12028-024-02100-4","DOIUrl":"10.1007/s12028-024-02100-4","url":null,"abstract":"","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"317-318"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-06-24DOI: 10.1007/s12028-024-02013-2
Kehinde Alare, Elishama Abioye, Biam Saydo
{"title":"Gerstmann Syndrome: What is the Possible Role of Deep Brain Stimulation?","authors":"Kehinde Alare, Elishama Abioye, Biam Saydo","doi":"10.1007/s12028-024-02013-2","DOIUrl":"10.1007/s12028-024-02013-2","url":null,"abstract":"<p><p>Gerstmann syndrome, characterized by a tetrad of symptoms, which are agraphia, acalculia, left-right disorientation, and finger agnosia, presents challenges in both understanding its pathophysiology and establishing effective treatment modalities. Neuroanatomical studies have highlighted the involvement of the dominant parietal lobe, particularly the inferior parietal lobule, in the development of Gerstmann syndrome. Although current treatment options are largely supportive, recent research suggests a potential role for deep brain stimulation (DBS) in managing this condition. DBS, known for its efficacy in various neurological disorders, has been hypothesized to modulate neuronal pathways associated with Gerstmann syndrome. However, clinical evidence supporting DBS in Gerstmann syndrome remains scarce, posing challenges in patient selection and ethical considerations. Future research should prioritize investigating the efficacy and safety of DBS in Gerstmann syndrome to improve patient outcomes and quality of life.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"26-31"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141446624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-08-08DOI: 10.1007/s12028-024-02072-5
Seungyon Koh, Sungju Park, Mijin Lee, Hanki Kim, Won Jung Lee, Jae-Myeong Lee, Jun Young Choi
{"title":"Assessing the Brain Death/Death by Neurologic Criteria Determination Process in Korea: Insights from 10-Year Noncompleted Donation Data.","authors":"Seungyon Koh, Sungju Park, Mijin Lee, Hanki Kim, Won Jung Lee, Jae-Myeong Lee, Jun Young Choi","doi":"10.1007/s12028-024-02072-5","DOIUrl":"10.1007/s12028-024-02072-5","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to analyze the current status of brain death/death by neurologic criteria (BD/DNC) determination in Korea over a decade, identifying key areas for improvement in the process.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of data from the Korea Organ Donation Agency spanning 2011 to 2021, focusing on donors whose donations were not completed. The study reviewed demographics, medical settings, diagnoses, and outcomes, with particular emphasis on cases classified as nonbrain death and those resulting in death by cardiac arrest during the BD/DNC assessment.</p><p><strong>Results: </strong>Of the 5047 patients evaluated for potential brain death from 2011 to 2021, 361 were identified as noncompleted donors. The primary reasons for noncompletion included nonbrain death (n = 68, 18.8%), cardiac arrests during the BD/DNC assessment process (n = 80, 22.2%), organ ineligibility (n = 151, 41.8%), and logistical and legal challenges (n = 62, 17.2%). Notably, 25 (36.8%) of them failed to meet the minimum clinical criteria, and 7 of them were potential cases of disagreement between the two clinical examinations. Additionally, most cardiac arrests (n = 44, 55.0%) occurred between the first and second examinations, indicating management challenges in critically ill patients during the assessment period.</p><p><strong>Conclusions: </strong>Our study highlights significant challenges in the BD/DNC determination process, including the need for improved consistency in neurologic examinations and the management of critically ill patients. The study underscores the importance of refining protocols and training to enhance the accuracy and reliability of brain death assessments, while also ensuring streamlined and effective organ donation practices.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"253-260"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-31DOI: 10.1007/s12028-024-02080-5
Teodor Svedung Wettervik, Anders Hånell, Kerstin M Ahlgren, Lars Hillered, Anders Lewén
{"title":"Preliminary Observations of the Loke Microdialysis in an Experimental Pig Model: Are We Ready for Continuous Monitoring of Brain Energy Metabolism?","authors":"Teodor Svedung Wettervik, Anders Hånell, Kerstin M Ahlgren, Lars Hillered, Anders Lewén","doi":"10.1007/s12028-024-02080-5","DOIUrl":"10.1007/s12028-024-02080-5","url":null,"abstract":"<p><strong>Background: </strong>Brain energy metabolism is often disturbed after acute brain injuries. Current neuromonitoring methods with cerebral microdialysis (CMD) are based on intermittent measurements (1-4 times/h), but such a low frequency could miss transient but important events. The solution may be the recently developed Loke microdialysis (MD), which provides high-frequency data of glucose and lactate. Before clinical implementation, the reliability and stability of Loke remain to be determined in vivo. The purpose of this study was to validate Loke MD in relation to the standard intermittent CMD method.</p><p><strong>Methods: </strong>Four pigs aged 2-3 months were included. They received two adjacent CMD catheters, one for standard intermittent assessments and one for continuous (Loke MD) assessments of glucose and lactate. The standard CMD was measured every 15 min. Continuous Loke MD was sampled every 2-3 s and was averaged over corresponding 15-min intervals for the statistical comparisons with standard CMD. Intravenous glucose injections and intracranial hypertension by inflation of an intracranial epidural balloon were performed to induce variations in intracranial pressure, cerebral perfusion pressure, and systemic and cerebral glucose and lactate levels.</p><p><strong>Results: </strong>In a linear mixed-effect model of standard CMD glucose (mM), there was a fixed effect value (± standard error [SE]) at 0.94 ± 0.07 (p < 0.001) for Loke MD glucose (mM), with an intercept at - 0.19 ± 0.15 (p = 0.20). The model showed a conditional R<sup>2</sup> at 0.81 and a marginal R<sup>2</sup> at 0.72. In a linear mixed-effect model of standard CMD lactate (mM), there was a fixed effect value (± SE) at 0.41 ± 0.16 (p = 0.01) for Loke MD lactate (mM), with an intercept at 0.33 ± 0.21 (p = 0.25). The model showed a conditional R<sup>2</sup> at 0.47 and marginal R<sup>2</sup> at 0.17.</p><p><strong>Conclusions: </strong>The established standard CMD glucose thresholds may be used as for Loke MD with some caution, but this should be avoided for lactate.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"222-231"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11811243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141860426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-02DOI: 10.1007/s12028-024-02036-9
Charlene J Ong, Qiuxi Huang, Ivy So Yeon Kim, Jack Pohlmann, Stefanos Chatzidakis, Benjamin Brush, Yihan Zhang, Yili Du, Leigh Ann Malinger, Emelia J Benjamin, Josée Dupuis, David M Greer, Stelios M Smirnakis, Ludovic Trinquart
{"title":"Association of Dynamic Trajectories of Time-Series Data and Life-Threatening Mass Effect in Large Middle Cerebral Artery Stroke.","authors":"Charlene J Ong, Qiuxi Huang, Ivy So Yeon Kim, Jack Pohlmann, Stefanos Chatzidakis, Benjamin Brush, Yihan Zhang, Yili Du, Leigh Ann Malinger, Emelia J Benjamin, Josée Dupuis, David M Greer, Stelios M Smirnakis, Ludovic Trinquart","doi":"10.1007/s12028-024-02036-9","DOIUrl":"10.1007/s12028-024-02036-9","url":null,"abstract":"<p><strong>Background: </strong>Life-threatening, space-occupying mass effect due to cerebral edema and/or hemorrhagic transformation is an early complication of patients with middle cerebral artery stroke. Little is known about longitudinal trajectories of laboratory and vital signs leading up to radiographic and clinical deterioration related to this mass effect.</p><p><strong>Methods: </strong>We curated a retrospective data set of 635 patients with large middle cerebral artery stroke totaling 95,463 data points for 10 longitudinal covariates and 40 time-independent covariates. We assessed trajectories of the 10 longitudinal variables during the 72 h preceding three outcomes representative of life-threatening mass effect: midline shift ≥ 5 mm, pineal gland shift (PGS) > 4 mm, and decompressive hemicraniectomy (DHC). We used a \"backward-looking\" trajectory approach. Patients were aligned based on outcome occurrence time and the trajectory of each variable was assessed before that outcome by accounting for cases and noncases, adjusting for confounders. We evaluated longitudinal trajectories with Cox proportional time-dependent regression.</p><p><strong>Results: </strong>Of 635 patients, 49.0% were female, and the mean age was 69 years. Thirty five percent of patients had midline shift ≥ 5 mm, 24.3% of patients had PGS > 4 mm, and 10.7% of patients underwent DHC. Backward-looking trajectories showed mild increases in white blood cell count (10-11 K/UL within 72 h), temperature (up to half a degree within 24 h), and sodium levels (1-3 mEq/L within 24 h) before the three outcomes of interest. We also observed a decrease in heart rate (75-65 beats per minute) 24 h before DHC. We found a significant association between increased white blood cell count with PGS > 4 mm (hazard ratio 1.05, p value 0.007).</p><p><strong>Conclusions: </strong>Longitudinal profiling adjusted for confounders demonstrated that white blood cell count, temperature, and sodium levels appear to increase before radiographic and clinical indicators of space-occupying mass effect. These findings will inform the development of multivariable dynamic risk models to aid prediction of life-threatening, space-occupying mass effect.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"77-89"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-02DOI: 10.1007/s12028-024-02051-w
Laura Sieh, Emma Peasley, Eric Mao, Amanda Mitchell, Gregory Heinonen, Shivani Ghoshal, Sachin Agarwal, Soojin Park, E Sander Connolly, Jan Claassen, Ernest E Moore, Kirk Hansen, Eldad A Hod, Richard O Francis, David J Roh
{"title":"Admission Viscoelastic Hemostatic Assay Parameters Predict Poor Long-Term Intracerebral Hemorrhage Outcomes.","authors":"Laura Sieh, Emma Peasley, Eric Mao, Amanda Mitchell, Gregory Heinonen, Shivani Ghoshal, Sachin Agarwal, Soojin Park, E Sander Connolly, Jan Claassen, Ernest E Moore, Kirk Hansen, Eldad A Hod, Richard O Francis, David J Roh","doi":"10.1007/s12028-024-02051-w","DOIUrl":"10.1007/s12028-024-02051-w","url":null,"abstract":"<p><strong>Background: </strong>Viscoelastic hemostatic assays (VHAs) provide more comprehensive assessments of coagulation compared with conventional coagulation assays. Although VHAs have enabled guided hemorrhage control therapies, improving clinical outcomes in life-threatening hemorrhage, the role of VHAs in intracerebral hemorrhage (ICH) is unclear. If VHAs can identify coagulation abnormalities relevant for ICH outcomes, this would support the need to investigate the role of VHAs in ICH treatment paradigms. Thus, we investigated whether VHA assessments of coagulation relate to long-term ICH outcomes.</p><p><strong>Methods: </strong>Patients with spontaneous ICH enrolled into a single-center cohort study receiving admission Rotational Thromboelastometry (ROTEM) VHA testing between 2013 and 2020 were assessed. Patients with previous anticoagulant use or coagulopathy on conventional coagulation assays were excluded. Primary ROTEM exposure variables were coagulation kinetics and clot strength assessments. Poor long-term outcome was defined as modified Rankin Scale ≥ 4 at 6 months. Logistic regression analyses assessed associations of ROTEM parameters with clinical outcomes after adjusting for ICH severity and hemoglobin concentration.</p><p><strong>Results: </strong>Of 44 patients analyzed, the mean age was 64 years, 57% were female, and the median ICH volume was 23 mL. Poor 6-month outcome was seen in 64% of patients. In our multivariable regression models, slower, prolonged coagulation kinetics (adjusted odds ratio for every second increase in clot formation time 1.04, 95% confidence interval 1.00-1.09, p = 0.04) and weaker clot strength (adjusted odds ratio for every millimeter increase of maximum clot firmness 0.84, 95% confidence interval 0.71-0.99, p = 0.03) were separately associated with poor long-term outcomes.</p><p><strong>Conclusions: </strong>Slower, prolonged coagulation kinetics and weaker clot strength on admission VHA ROTEM testing, not attributable to anticoagulant use, were associated with poor long-term outcomes after ICH. Further work is needed to clarify the generalizability and the underlying mechanisms of these VHA findings to assess whether VHA-guided treatments should be incorporated into ICH care.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"100-107"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Megan E Barra, Elizabeth K Zink, Thomas P Bleck, Eder Cáceres, Salia Farrokh, Brandon Foreman, Emilio Garzón Cediel, J Claude Hemphill, Masao Nagayama, DaiWai M Olson, Jose I Suarez
{"title":"Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Hospital Course, Confounders, and Medications.","authors":"Megan E Barra, Elizabeth K Zink, Thomas P Bleck, Eder Cáceres, Salia Farrokh, Brandon Foreman, Emilio Garzón Cediel, J Claude Hemphill, Masao Nagayama, DaiWai M Olson, Jose I Suarez","doi":"10.1007/s12028-024-02099-8","DOIUrl":"10.1007/s12028-024-02099-8","url":null,"abstract":"","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"321-322"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}